Tracheostomy Practice in Adult Intensive Care Units

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Royal College of Surgeons, Ireland
Study ID
NCT07769021
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Intensive Care (ICU)
  • Tracheostomy Decannulation
  • Tracheostomy Patients

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

ON TRACH is an international, multicentre, observational study with the aim of characterising the timing and practice of tracheostomy insertion, management, weaning and longer-term outcomes of these patients, in intensive care units internationally. Participating intensive care units (ICU) will recruit all consecutive patients undergoing tracheostomy insertion over a 12 week period, aiming for broad global representation. This will allow identification of variation in care of patients with a tracheostomy in the intensive care and it's origin, to drive improvement and enhance safety and outcomes for patients with a tracheostomy in the future.

Key Dates

First listed
Aug 17, 2026
Start date
Nov 2, 2026
Status verified
Jul 2026
Primary completion
Nov 30, 2028
Completion
Mar 31, 2029

Study Design

Enrollment
2,500 participants (estimated)

Arms

  • Arm: Critical care patients with a tracheostomy
    Participants will include patients 18 years and older, admitted to the intensive care, who undergo tracheostomy insertion as part of their critical care admission.

Primary Outcome Measure

Successful tracheostomy decannulation [ Time Frame: 90 days ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Beth Israel Medical CentreBostonMassachusetts02215
Elisabeth Riviello, MD
617-667-7000
Elisabeth Riviello, MD (PRINCIPAL_INVESTIGATOR)
University of Michigan Health Ann ArborAnn ArborMichigan48109
Michael Brenner, MD
734-936-4000
Michael Brenner, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA